HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--July 6, 2006--Nymox Pharmaceutical Corporation (NASDAQ:NYMX - News) is pleased to announce that results from clinical studies of the Company’s NicAlert(TM) Saliva test for tobacco product use and exposure will be presented at the 13th World Conference on Tobacco or Health in Washington DC on July 12. The World Conference includes the top experts on nicotine and tobacco from around the world.
